{"transactions":[{"id":1585852,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-08T21:17:23.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 7, 2025 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":168750,"derivative":{"exercise_price":9.58,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001562180-24-002477","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218024002477/primarydocument.xml","form_type":"4"}},{"id":1585851,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-08T21:17:23.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 7, 2025, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 7, 2025, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001562180-24-002477","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218024002477/primarydocument.xml","form_type":"4"}},{"id":1706581,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-12-18T21:51:03.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":4.0013,"value":300097.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021, as modified on April 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.93 to $4.10, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":867455,"source":{"system":"sec-edgar","filing":"0001562180-23-008445","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218023008445/primarydocument.xml","form_type":"4"}},{"id":1749297,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-03T20:08:48.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in full on January 2, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in full on January 2, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-23-007550","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218023007550/primarydocument.xml","form_type":"4"}},{"id":1971211,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-03T21:36:18.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 2, 2024 and in 36 equal monthly installments thereafter."}],"balance_after":185000,"derivative":{"exercise_price":3.76,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001562180-23-002398","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218023002398/primarydocument.xml","form_type":"4"}},{"id":2343423,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-03-08T14:05:04.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 3, 2023 and in 36 equal monthly installments thereafter."}],"balance_after":225000,"derivative":{"exercise_price":5.7,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001562180-22-002427","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218022002427/primarydocument.xml","form_type":"4"}},{"id":2570298,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-14T20:05:29.000Z","date":"2021-09-10","kind":"sale","acquired":false,"shares":1477,"price":25,"value":36925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."}],"balance_after":942455,"source":{"system":"sec-edgar","filing":"0001562180-21-005940","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005940/primarydocument.xml","form_type":"4"}},{"id":2572810,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-10T23:27:12.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":39205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter."}],"balance_after":88803,"derivative":{"exercise_price":1.48,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":39205},"source":{"system":"sec-edgar","filing":"0001562180-21-005916","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005916/primarydocument.xml","form_type":"4"}},{"id":2572809,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-10T23:27:12.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":25466,"price":25.0081,"value":636856.2746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive."}],"balance_after":943932,"source":{"system":"sec-edgar","filing":"0001562180-21-005916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005916/primarydocument.xml","form_type":"4"}},{"id":2572808,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-10T23:27:12.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":39205,"price":25.013,"value":980634.665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.18, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":969398,"source":{"system":"sec-edgar","filing":"0001562180-21-005916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005916/primarydocument.xml","form_type":"4"}},{"id":2572807,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-10T23:27:12.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":39205,"price":1.48,"value":58023.4,"ownership":{"direct":true},"balance_after":1008603,"source":{"system":"sec-edgar","filing":"0001562180-21-005916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005916/primarydocument.xml","form_type":"4"}},{"id":2576824,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-07T23:29:33.000Z","date":"2021-09-03","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter."}],"balance_after":128008,"derivative":{"exercise_price":1.48,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001562180-21-005865","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005865/primarydocument.xml","form_type":"4"}},{"id":2576823,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-07T23:29:33.000Z","date":"2021-09-02","kind":"exercise","acquired":false,"shares":6558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter."}],"balance_after":128708,"derivative":{"exercise_price":1.48,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":6558},"source":{"system":"sec-edgar","filing":"0001562180-21-005865","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005865/primarydocument.xml","form_type":"4"}},{"id":2576822,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-07T23:29:33.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":700,"price":25,"value":17500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."}],"balance_after":969398,"source":{"system":"sec-edgar","filing":"0001562180-21-005865","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005865/primarydocument.xml","form_type":"4"}},{"id":2576821,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-07T23:29:33.000Z","date":"2021-09-03","kind":"exercise","acquired":true,"shares":700,"price":1.48,"value":1036.0,"ownership":{"direct":true},"balance_after":970098,"source":{"system":"sec-edgar","filing":"0001562180-21-005865","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005865/primarydocument.xml","form_type":"4"}},{"id":2576820,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-07T23:29:33.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":1400,"price":25.0039,"value":35005.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.015, inclusive."}],"balance_after":969398,"source":{"system":"sec-edgar","filing":"0001562180-21-005865","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005865/primarydocument.xml","form_type":"4"}},{"id":2576819,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-07T23:29:33.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":6558,"price":25.0019,"value":163962.4602,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":970798,"source":{"system":"sec-edgar","filing":"0001562180-21-005865","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005865/primarydocument.xml","form_type":"4"}},{"id":2576818,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-07T23:29:33.000Z","date":"2021-09-02","kind":"exercise","acquired":true,"shares":6558,"price":1.48,"value":9705.84,"ownership":{"direct":true},"balance_after":977356,"source":{"system":"sec-edgar","filing":"0001562180-21-005865","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005865/primarydocument.xml","form_type":"4"}},{"id":2578283,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T20:12:30.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":1134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter."}],"balance_after":135266,"derivative":{"exercise_price":1.48,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":1134},"source":{"system":"sec-edgar","filing":"0001562180-21-005810","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005810/primarydocument.xml","form_type":"4"}},{"id":2578282,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:12:30.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":3002,"price":25.0057,"value":75067.1114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.03, inclusive."}],"balance_after":970798,"source":{"system":"sec-edgar","filing":"0001562180-21-005810","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005810/primarydocument.xml","form_type":"4"}},{"id":2578281,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:12:30.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":1134,"price":25.0036,"value":28354.0824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":973800,"source":{"system":"sec-edgar","filing":"0001562180-21-005810","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005810/primarydocument.xml","form_type":"4"}},{"id":2578280,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:12:30.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":1134,"price":1.48,"value":1678.32,"ownership":{"direct":true},"balance_after":974934,"source":{"system":"sec-edgar","filing":"0001562180-21-005810","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005810/primarydocument.xml","form_type":"4"}},{"id":2583039,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-01T20:20:35.000Z","date":"2021-08-30","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter."}],"balance_after":136400,"derivative":{"exercise_price":1.48,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001562180-21-005697","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005697/primarydocument.xml","form_type":"4"}},{"id":2583038,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-01T20:20:35.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":1200,"price":25.0183,"value":30021.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.000 to $25.025, inclusive."}],"balance_after":973800,"source":{"system":"sec-edgar","filing":"0001562180-21-005697","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005697/primarydocument.xml","form_type":"4"}},{"id":2583037,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-01T20:20:35.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":1100,"price":25.01,"value":27511.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.03, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":975000,"source":{"system":"sec-edgar","filing":"0001562180-21-005697","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005697/primarydocument.xml","form_type":"4"}},{"id":2583036,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":93293,"kind":"person","name":"Hordo Christian","position":1,"cik":"0001830070","reported_name":"Hordo Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-09-01T20:20:35.000Z","date":"2021-08-30","kind":"exercise","acquired":true,"shares":1100,"price":1.48,"value":1628.0,"ownership":{"direct":true},"balance_after":976100,"source":{"system":"sec-edgar","filing":"0001562180-21-005697","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218021005697/primarydocument.xml","form_type":"4"}}]}